A detailed history of Advisor Shares Investments LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Advisor Shares Investments LLC holds 43,882 shares of CMPS stock, worth $374,752. This represents 0.07% of its overall portfolio holdings.

Number of Shares
43,882
Previous 60,882 27.92%
Holding current value
$374,752
Previous $519,000 27.94%
% of portfolio
0.07%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-17,000 Reduced 27.92%
43,882 $374,000
Q2 2024

Aug 07, 2024

BUY
N/A
7,243 Added 13.5%
60,882 $519,000
Q1 2024

May 14, 2024

SELL
N/A
-22,182 Reduced 29.26%
53,639 $458,000
Q4 2023

Feb 13, 2024

SELL
N/A
-13,697 Reduced 15.3%
75,821 $647,000
Q3 2023

Nov 06, 2023

BUY
N/A
20 Added 0.02%
89,518 $764,000
Q2 2023

Aug 09, 2023

BUY
$7.79 - $10.69 $17,067 - $23,421
2,191 Added 2.51%
89,498 $764,000
Q1 2023

May 09, 2023

SELL
$7.32 - $10.85 $22,992 - $34,079
-3,141 Reduced 3.47%
87,307 $866,000
Q4 2022

Feb 14, 2023

BUY
$7.84 - $11.68 $59,270 - $88,300
7,560 Added 9.12%
90,448 $726,000
Q3 2022

Nov 14, 2022

BUY
$10.73 - $20.07 $241,854 - $452,377
22,540 Added 37.35%
82,888 $889,000
Q2 2022

Aug 08, 2022

BUY
$6.76 - $14.18 $54,891 - $115,141
8,120 Added 15.55%
60,348 $653,000
Q1 2022

May 09, 2022

BUY
$11.13 - $23.04 $207,240 - $429,004
18,620 Added 55.4%
52,228 $673,000
Q4 2021

Jan 31, 2022

BUY
$21.81 - $48.96 $473,255 - $1.06 Million
21,699 Added 182.21%
33,608 $743,000
Q3 2021

Nov 04, 2021

BUY
$29.03 - $38.62 $132,347 - $176,068
4,559 Added 62.03%
11,909 $356,000
Q2 2021

Jul 27, 2021

SELL
$32.29 - $39.68 $135,618 - $166,656
-4,200 Reduced 36.36%
7,350 $280,000
Q1 2021

May 11, 2021

BUY
$34.75 - $57.5 $401,362 - $664,125
11,550 New
11,550 $425,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Advisor Shares Investments LLC Portfolio

Follow Advisor Shares Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.